June 20, 2023
The Seventh Circuit on Tuesday affirmed a lower court's ruling not to give a new trial to a man who opted out of a global settlement with Actavis over allegations that the company's testosterone replacement drug caused heart attacks, saying that newly surfaced research documents did not favor him.